Oxaliplatin and Bortezomib in Treating Patients With Advanced Cancer

Clinical trial NCT00066625 · TERMINATED

Trial details

NCT number: NCT00066625
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2003-07-01
Primary completion: 2007-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.